# Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation

Study · id `cardio:ct-nct02424110` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02424110](<https://clinicaltrials.gov/study/NCT02424110>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02424110

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02424110. Randomized; double masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2018-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02424110, source copy `cardio:ctgov-nct02424110-2017-01-27`, retrieved 2026-10-26)
- Start date: 2015-07 (registry gives no type) (ClinicalTrials.gov record NCT02424110, source copy `cardio:ctgov-nct02424110-2017-01-27`, retrieved 2026-10-26)
- Primary completion: 2018-05 (anticipated) (ClinicalTrials.gov record NCT02424110, source copy `cardio:ctgov-nct02424110-2017-01-27`, retrieved 2026-10-26)
- Completion: 2018-05 (anticipated) (ClinicalTrials.gov record NCT02424110, source copy `cardio:ctgov-nct02424110-2017-01-27`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02424110, source copy `cardio:ctgov-nct02424110-2017-01-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02424110-2017-01-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation
- Condition: Atrial Fibrillation
- Intervention (Procedure): argon beam coagulator ablation
- Intervention (Procedure): bipolar radiofrequency ablation
- Intervention (Device): argon beam coagulator （American，Valleylab）
- Intervention (Device): bipolar radiofrequency (AtricuteTM)
- Lead sponsor: Xinqiao Hospital of Chongqing
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Xinqiao Hospital of Chongqing (`cardio:org-xinqiao-hospital-of-chongqing`)

## Provenance

Content hash: b5c9146812c9c5a2aba16759c4230029582ce956a212191170f908fc7c132093
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
